Published in BMJ on October 18, 2011
Chronic hypertension and pregnancy outcomes: systematic review and meta-analysis. BMJ (2014) 1.80
Hypertension in women of reproductive age in the United States: NHANES 1999-2008. PLoS One (2012) 1.13
Patterns of outpatient antihypertensive medication use during pregnancy in a Medicaid population. Hypertension (2012) 1.04
Pregnancy after acute coronary syndrome: a proposal for patients' management and a literature review. Biomed Res Int (2013) 0.90
Nongenetic risk factors and congenital heart defects. Pediatr Cardiol (2013) 0.90
Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol (2014) 0.89
Managing type 1 diabetes mellitus in pregnancy--from planning to breastfeeding. Nat Rev Endocrinol (2012) 0.89
The risk of congenital malformations associated with exposure to β-blockers early in pregnancy: a meta-analysis. Hypertension (2013) 0.84
Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study. PLoS One (2013) 0.83
Prescription of antihypertensive medications during pregnancy in the UK. Pharmacoepidemiol Drug Saf (2014) 0.82
Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry. Drug Saf (2015) 0.81
Management of Type 1 Diabetes in Pregnancy. Curr Diab Rep (2016) 0.80
Hypertension: ACE inhibitor use in pregnancy--setting the record straight. Nat Rev Cardiol (2011) 0.80
The management of hypertension in pregnancy. Adv Chronic Kidney Dis (2013) 0.80
Exposure of drugs for hypertension, diabetes, and autoimmune disease during pregnancy and perinatal outcomes: an investigation of the regulator in Japan. Medicine (Baltimore) (2015) 0.78
EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations. Br J Clin Pharmacol (2016) 0.78
Fetal risk from ACE inhibitors in the first trimester. BMJ (2011) 0.78
Maternal Hypertension During Pregnancy and the Risk of Congenital Heart Defects in Offspring: A Systematic Review and Meta-analysis. Pediatr Cardiol (2015) 0.78
Managing pregnancy in chronic kidney disease: improving outcomes for mother and baby. Int J Womens Health (2016) 0.75
Angiotensin-Converting Enzyme Inhibitors and the Risk of Congenital Malformations. Obstet Gynecol (2016) 0.75
Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines. Clin J Am Soc Nephrol (2016) 0.75
The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update. J Womens Health (Larchmt) (2016) 0.75
The relevance of the Renin-Angiotensin system in the development of drugs to combat preeclampsia. Int J Endocrinol (2015) 0.75
Improving Information on Maternal Medication Use by Linking Prescription Data to Congenital Anomaly Registers: A EUROmediCAT Study. Drug Saf (2015) 0.75
Antihypertensives in pregnancy. Rev Obstet Gynecol (2012) 0.75
Hypertension in pregnancy: a review of therapeutic options. Obstet Med (2012) 0.75
Reversible Fetal Renal Impairment following Angiotensin Receptor Blocking Treatment during Third Trimester of Pregnancy: Case Report and Review of the Literature. Case Rep Obstet Gynecol (2016) 0.75
In-utero exposure to antihypertensive medication and neonatal and child health outcomes: a systematic review. J Hypertens (2017) 0.75
Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83
Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care (2001) 3.27
Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes: the Northern California Kaiser Permanente Diabetes Registry, 1995-1998. Circulation (2003) 2.32
Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol (2009) 1.56
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Teratogen update: angiotensin-converting enzyme inhibitors. Teratology (1994) 1.22
Taking ACE inhibitors during pregnancy. Is it safe? Can Fam Physician (2002) 1.09
Postmarketing surveillance for angiotensin-converting enzyme inhibitor use during the first trimester of pregnancy--United States, Canada, and Israel, 1987-1995. MMWR Morb Mortal Wkly Rep (1997) 1.06
Chronic hypertension with related drug treatment of pregnant women and congenital abnormalities in their offspring: a population-based study. Hypertens Res (2010) 1.05
ACE inhibitors and congenital anomalies. N Engl J Med (2006) 1.01
Actual versus projected cost avoidance for clinical pharmacy specialist-initiated medication conversions in a primary care setting in an integrated health system. J Manag Care Pharm (2008) 0.98
High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett (2006) 3.64
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat Biotechnol (2009) 2.76
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat Med (2010) 2.41
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Potential medication dosing errors in outpatient pediatrics. J Pediatr (2005) 2.19
Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy. Cancer Res (2009) 1.46
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr (2010) 1.30
Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation. Proc Natl Acad Sci U S A (2012) 1.26
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons. Clin Infect Dis (2013) 1.18
Ca2+/calmodulin-dependent protein kinase II-dependent remodeling of Ca2+ current in pressure overload heart failure. J Biol Chem (2008) 1.16
Missense mutations in the MEFV gene are associated with fibromyalgia syndrome and correlate with elevated IL-1beta plasma levels. PLoS One (2009) 1.02
Rate and extent of phagocytosis in macrophages lacking vamp3. J Leukoc Biol (2002) 1.00
MECP2 coding sequence and 3'UTR variation in 172 unrelated autistic patients. Am J Med Genet B Neuropsychiatr Genet (2007) 0.99
Exposure to magnetic fields and the risk of poor sperm quality. Reprod Toxicol (2009) 0.93
Syntaxin 4 expression affects glucose transporter 8 translocation and embryo survival. Mol Endocrinol (2003) 0.89
Results of a pilot study using self-collected mid-turbinate nasal swabs for detection of influenza virus infection among pregnant women. Influenza Other Respir Viruses (2015) 0.88
Validation of anaphylaxis in the Food and Drug Administration's Mini-Sentinel. Pharmacoepidemiol Drug Saf (2013) 0.87
Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer. PLoS One (2013) 0.86
SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt. J Hematol Oncol (2013) 0.86
-216G/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma. Oncol Lett (2013) 0.85
Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation. Mol Cancer Ther (2009) 0.85
A highly selective space-folded photo-induced electron transfer fluorescent probe for carbonic anhydrase isozymes IX and its applications for biological imaging. Chem Commun (Camb) (2011) 0.84
E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. J Gene Med (2009) 0.83
Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Leuk Lymphoma (2008) 0.83
Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J (2013) 0.82
Sulfoalkylbetaine-based monolithic column with mixed-mode of hydrophilic interaction and strong anion-exchange stationary phase for capillary electrochromatography. Electrophoresis (2010) 0.82
The microtubule depolymerizing agent CYT997 effectively kills acute myeloid leukemia cells via activation of caspases and inhibition of PI3K/Akt/mTOR pathway proteins. Exp Ther Med (2013) 0.81
Antitumor activity of fludarabine against human multiple myeloma in vitro and in vivo. Eur J Haematol (2007) 0.80
A prospective study of in-utero exposure to magnetic fields and the risk of childhood obesity. Sci Rep (2012) 0.79
The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007. Matern Child Health J (2014) 0.78
Versatile trifunctional chemosensor of rhodamine derivative for Zn2+, Cu2+ and His/Cys in aqueous solution and living cells. Org Biomol Chem (2011) 0.78
Modeling of oxygen transport and cell killing in type-II photodynamic therapy. Photochem Photobiol (2012) 0.78
Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening. Bioorg Med Chem Lett (2013) 0.76
Association of roasting meat intake with the risk of esophageal squamous cell carcinoma of Kazakh Chinese via affecting promoter methylation of p16 gene. Asia Pac J Clin Nutr (2014) 0.76
Refractory multiple myeloma treated with homoharringtonine: report of two cases. Ann Hematol (2007) 0.76
Rapid capillary electrochromatographic profiling of phytohormones on a hydrophilic interaction/strong anion-exchange mixed-mode monolith. Analyst (2013) 0.76
Risk of congenital malformations among infants exposed to antidepressants during pregnancy. Pharmacoepidemiol Drug Saf (2008) 0.75
Clinical characteristics of angioimmunoblastic T-cell lymphoma in China and C-reactive protein as an independent prognostic factor. Medicine (Baltimore) (2017) 0.75
Highly selective, naked-eye and fluorescent "off-on" probe for detection of histidine/histidine-rich proteins and its application in living cell imaging. Org Biomol Chem (2012) 0.75
Linkage analysis of five Chinese families with arrhythmogenic right ventricular cardiomyopathy using microsatellite genetic markers. Chin Med J (Engl) (2003) 0.75
Study on a quantitative electroencephalography power spectrum typical of Chinese Han Alzheimer's disease patients by using wavelet transforms. J Neural Eng (2006) 0.75
A ratiometric fluorescent probe for oxalate based on alkyne-conjugated carboxamidoquinolines in aqueous solution and imaging in living cells. Dalton Trans (2010) 0.75
A highly selective and sensitive fluorescence "turn-on" probe for Ag+ in aqueous solution and live cells. Dalton Trans (2012) 0.75